Selten Revenue and S Korean gov't fundingNexoptic is looking juicy at this price point.
Further dilution appears to no be necessary.
Research team working on all cyclinders, and a LOT is happenng behind the scenes.
We have a lowball bid in for this one.
Thanks to the bashers for getting the price down to where we are.
Spooking retail creates buy opportunities for hte astute and wise.